Connecticut 2019 Regular Session

Connecticut House Bill HB07287 Latest Draft

Bill / Comm Sub Version Filed 04/11/2019

                             
 
LCO    \\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07287-R01-
HB.docx  
1 of 3 
 
General Assembly  Substitute Bill No. 7287  
January Session, 2019 
 
 
 
 
 
AN ACT CONCERNING RE VISIONS TO THE MEDICAL MARIJUANA 
PROGRAM.  
Be it enacted by the Senate and House of Representatives in General 
Assembly convened: 
 
Section 1. Subdivision (3) of section 21a-408 of the general statutes is 1 
repealed and the following is substituted in lieu thereof (Effective from 2 
passage): 3 
(3) "Debilitating medical condition" means (A) cancer, glaucoma, 4 
positive status for human immunodeficiency virus or acquired 5 
immune deficiency syndrome, Parkinson's disease, multiple sclerosis, 6 
damage to the nervous tissue of the spinal cord with objective 7 
neurological indication of intractable spasticity, epilepsy or 8 
uncontrolled intractable seizure disorder, cachexia, wasting syndrome, 9 
Crohn's disease, posttraumatic stress disorder, irreversible spinal cord 10 
injury with objective neurological indication of intractable spasticity, 11 
cerebral palsy, cystic fibrosis, [or] terminal illness requiring end-of-life 12 
care, or opioid use disorder, except, if the qualifying patient is under 13 
eighteen years of age, "debilitating medical condition" means terminal 14 
illness requiring end-of-life care, irreversible spinal cord injury with 15 
objective neurological indication of intractable spasticity, cerebral 16 
palsy, cystic fibrosis, severe epilepsy or uncontrolled intractable 17 
seizure disorder, or (B) any medical condition, medical treatment or 18 
disease approved for qualifying patients by the Department of 19  Substitute Bill No. 7287 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07287-
R01-HB.docx }   
2 of 3 
 
Consumer Protection pursuant to regulations adopted under section 20 
21a-408m; 21 
Sec. 2. Subsection (a) of section 21a-408d of the general statutes is 22 
repealed and the following is substituted in lieu thereof (Effective from 23 
passage): 24 
(a) Each qualifying patient who is issued a written certification for 25 
the palliative use of marijuana under subdivision (1) of subsection (a) 26 
of section 21a-408a, and the primary caregiver of such qualifying 27 
patient, shall register with the Department of Consumer Protection. 28 
Such registration shall be effective from the date the Department of 29 
Consumer Protection issues a certificate of registration until the 30 
expiration of the written certification issued by the physician or 31 
advanced practice registered nurse. The qualifying patient and the 32 
primary caregiver shall provide sufficient identifying information, as 33 
determined by the department, to establish the personal identity of the 34 
qualifying patient and the primary caregiver. If the qualifying patient 35 
is under eighteen years of age and not an emancipated minor, the 36 
custodial parent, guardian or other person having legal custody of the 37 
qualifying patient shall also provide a letter from both the qualifying 38 
patient's primary care provider and a physician who is board certified 39 
in an area of medicine involved in the treatment of the debilitating 40 
condition for which the qualifying patient was certified that confirms 41 
that the palliative use of marijuana is in the best interest of the 42 
qualifying patient. A physician may issue a written certification for the 43 
palliative use of marijuana by a qualifying patient who is under 44 
eighteen years of age, provided such written certification shall not be 45 
for marijuana in a dosage form that requires that the marijuana be 46 
smoked, inhaled or vaporized. The qualifying patient or the primary 47 
caregiver shall report any change in the identifying information to the 48 
department not later than five business days after such change. The 49 
department shall issue a registration certificate to the qualifying 50 
patient and to the primary caregiver [and may charge a reasonable fee, 51 
not to exceed twenty-five dollars, for each registration certificate 52  Substitute Bill No. 7287 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07287-
R01-HB.docx }   
3 of 3 
 
issued under this subsection] at no charge. [Any registration fees 53 
collected by the department under this subsection shall be paid to the 54 
State Treasurer and credited to the General Fund.] 55 
Sec. 3. (NEW) (Effective from passage) The Commissioner of 56 
Consumer Protection shall cease charging the nonrefundable fee for 57 
administrative costs for each qualifying patient and the nonrefundable 58 
application fee for each qualifying patient and caregiver under chapter 59 
420f of the general statutes. The commissioner shall also cease charging 60 
the renewal fee for each qualifying patient under chapter 420f of the 61 
general statutes. The commissioner shall amend existing regulations to 62 
eliminate such fees in accordance with the provisions of this section. 63 
This act shall take effect as follows and shall amend the following 
sections: 
 
Section 1 from passage 21a-408(3) 
Sec. 2 from passage 21a-408d(a) 
Sec. 3 from passage New section 
 
GL Joint Favorable Subst.